zur Navigation zum Inhalt
Onkologie 13. April 2010

Swiss trials in thoracic oncology

The Swiss Group for Clinical Cancer Research (SAKK) is a non-profit organization that conducts multicentre clinical trials for patients with many different types of cancer, including thoracic malignancies. This article summarizes the history and structure of the SAKK, and discusses the rationale and the present status of active SAKK trials in patients with non-small cell lung cancer, small cell lung cancer and malignant mesothelioma.

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben